<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2026-105-2-207-213</article-id><article-id custom-type="edn" pub-id-type="custom">flrmmn</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-5475</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОФИЛАКТИЧЕСКАЯ ТОКСИКОЛОГИЯ И ГИГИЕНИЧЕСКОЕ НОРМИРОВАНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PREVENTIVE TOXICOLOGY AND HYGIENIC STANDARTIZATION</subject></subj-group></article-categories><title-group><article-title>Биологическая активность левоглюкозенона и его производных (аналитический обзор)</article-title><trans-title-group xml:lang="en"><trans-title>Biological activity of levoglucosenone and its derivatives (analytical review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-9931-911X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ахметдинова</surname><given-names>Наталья Павловна</given-names></name><name name-style="western" xml:lang="en"><surname>Akhmetdinova</surname><given-names>Natalya P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Канд. хим. наук, науч. сотр. УфИХ РАН, 450054, Уфа, Россия</p><p>e-mail: breeze-o@yandex.ru</p></bio><bio xml:lang="en"><p>PhD (Chemistry), researcher, Ufa Institute of Chemistry, Ufa, 450054, Russian Federation</p><p>e-mail: breeze-o@yandex.ru</p></bio><email xlink:type="simple">breeze-o@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9302-499X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самородов</surname><given-names>Александр Владимирович</given-names></name><name name-style="western" xml:lang="en"><surname>Samorodov</surname><given-names>Aleksandr V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор мед. наук, профессор, гл. науч. сотр. ФГБНУ ВИЛАР, 117216, Москва, Россия</p><p>e-mail: AVSamorodov@gmail.com</p></bio><bio xml:lang="en"><p>DSc (Medicine), professor, chief researcher, Russian Scientific Research Institute of Medicinal and Aromatic Plants, Moscow, 117216, Russian Federation</p><p>e-mail: AVSamorodov@gmail.com</p></bio><email xlink:type="simple">AVSamorodov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2552-1833</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Файзуллина</surname><given-names>Лилия Халитовна</given-names></name><name name-style="western" xml:lang="en"><surname>Faizullina</surname><given-names>Liliya Kh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор хим. наук, доцент, вед. науч. сотр., зав. лаб. УфИХ РАН, 450054, Уфа, Россия</p><p>e-mail: sinvmet@anrb.ru</p></bio><bio xml:lang="en"><p>DSc (Chemistry), associate professor, leading researcher, head, Laboratory, Ufa Institute of Chemistry, Ufa, 450054, Russian Federation</p><p>e-mail: sinvmet@anrb.ru</p></bio><email xlink:type="simple">sinvmet@anrb.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБНУ «Уфимский институт химии» УФИЦ РАН<country>Россия</country></aff><aff xml:lang="en">Ufa Institute of Chemistry<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБНУ «Всероссийский научно-исследовательский институт лекарственных и ароматических растений»; ФГБНУ «Федеральный научно-клинический центр реаниматологии и реабилитологии»<country>Россия</country></aff><aff xml:lang="en">Russian Scientific Research Institute of Medicinal and Aromatic Plants; Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>13</day><month>03</month><year>2026</year></pub-date><volume>105</volume><issue>2</issue><fpage>207</fpage><lpage>213</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ахметдинова Н.П., Самородов А.В., Файзуллина Л.Х., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Ахметдинова Н.П., Самородов А.В., Файзуллина Л.Х.</copyright-holder><copyright-holder xml:lang="en">Akhmetdinova N.P., Samorodov A.V., Faizullina L.K.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/5475">https://www.rjhas.ru/jour/article/view/5475</self-uri><abstract><sec><title>Введение</title><p>Введение. Левоглюкозенон (ЛГ) – енон углеводной природы, получаемый кислотным пиролизом целлюлозы. С учётом мощного синтетического потенциала и доступности ЛГ мы посчитали интересным изучить его возможности как платформы в синтезе широкого круга хиральных органических молекул с целью выявления биологической активности полученных производных.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Прогнозирование биологических свойств ЛГ и его синтезированных в лаборатории фармакофорных циклических систем УфИХ УФИЦ РАН производных осуществлено с помощью компьютерной программы PASS. Проведены биологические испытания ЛГ и его производных.</p></sec><sec><title>Результаты</title><p>Результаты. Впервые изучена острая токсичность ЛГ, выявлены цитотоксические, фунгистатические, бактериостатические, антиагрегационные, антикоагулянтные, антиоксидантные свойства ЛГ и его производных.</p></sec><sec><title>Ограничения исследования</title><p>Ограничения исследования. Высокая стоимость биологических испытаний соединений.</p></sec><sec><title>Заключение</title><p>Заключение. Безусловно, внимание исследователей к ЛГ оправдано его активированным для дальнейших превращений строением и биологической активностью как самой молекулы, так и её производных. Среди исследуемых соединений выявлены лидеры по биологической активности, при этом ЛГ и его производные являются хиральными органическими молекулами и представляют интерес для библиотек соединений с необходимым биологическим действием. Данная статья может представлять интерес для учёных, работающих в области поиска полученных из доступных природных объектов новых перспективных хиральных молекул с целью выявления их фармакологического потенциала и дальнейшего использования в медицине.</p><p>Соблюдение этических стандартов. Протокол № 8 семинара по органической и биоорганической химии Уфимского института химии УФИЦ РАН от 10.04.2025 г.</p></sec><sec><title>Вклад авторов</title><p>Вклад авторов: Ахметдинова Н.П. – сбор материала и обработка данных, написание текста; Файзуллина Л.Х. – концепция и дизайн исследования, редактирование; Самородов А.В. – концепция и дизайн исследования, редактирование. Все соавторы – утверждение окончательного варианта статьи и ответственность за целостность всех её частей.</p></sec><sec><title>Конфликт интересов</title><p>Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов в связи с публикацией данной статьи.</p></sec><sec><title>Финансирование</title><p>Финансирование. Исследование поддержано государственным заданием Уфимского института химии УФИЦ РАН по теме «Разработка стратегий и методов целенаправленного синтеза практически важных веществ на основе фундаментальных исследований свойств природных соединений и продуктов органического синтеза» (государственная регистрация – № 125020601627-6).</p></sec><sec><title>Поступила</title><p>Поступила: 23.04.2025 / Принята к печати: 02.12.2025 / Опубликована: 13.03.2026</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Levoglucosenone (LG) is an enone of a carbohydrate nature obtained by acid pyrolysis of cellulose. Given the high synthetic potential and availability of LG, we found it interesting to study its potential as a platform for the synthesis of a wide range of biologically active compounds to identify the biological activity of the derivatives obtained.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The prediction of the biological properties of LG and its derivatives synthesized in the Laboratory of cyclic pharmacophore systems of the Ufa Institute of Chemistry was carried out using the PASS-computer software. Biological tests of LG and its derivatives were performed.</p></sec><sec><title>Results</title><p>Results. The acute toxicity of LG was studied for the first time, and cytotoxic, fungistatic, bacteriostatic, anti-aggregation, anticoagulant and antioxidant properties of LG and its derivatives were demonstrated.</p></sec><sec><title>Limitations</title><p>Limitations. Limited financial availability of biological trials of synthesized LG demonstrated.</p></sec><sec><title>Conclusion</title><p>Conclusion. Of course, the LG molecule deserves the attention of researchers with its structure activated for further transformations and the study of the biological activity in LG and its derivatives. Leaders in biological activity have been identified among the compounds studied, with LG and its derivatives being chiral organic molecules and of interest for libraries of compounds with necessary biological activities. This article will be useful for scientists interested in searching for new promising chiral molecules derived from available natural objects to identify their pharmacological potential with the aim of further use in medicine.</p><p>Compliance with ethical standards. Protocol № 8 of the Seminar on Organic and Bioorganic Chemistry of the Ufa Institute of Chemistry dated 04/10/2025.</p></sec><sec><title>Contribution</title><p>Contribution: Akhmetdinova N.P. – collection of material and data processing, writing text; Faizullina L.Kh. – concept and design of the study, editing; Samorodov A.V. – concept and design of the study, editing. All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.</p></sec><sec><title>Conflict of interest</title><p>Conflict of interest. The authors declare no conflict of interest.</p></sec><sec><title>Funding</title><p>Funding. The research was supported by the State Assignment of the Ufa Institute of Chemistry, on the topic «Development of strategies and methods for the targeted synthesis of practically important substances based on fundamental studies of the properties of natural compounds and organic synthesis products» (state registration № 125020601627-6).</p></sec><sec><title>Received</title><p>Received: April 23, 2025 / Accepted: December 2, 2025 / Published: March 13, 2026</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>левоглюкозенон</kwd><kwd>антиоксидантная активность</kwd><kwd>антиагрегационная активность</kwd><kwd>цитотоксическая активность</kwd><kwd>фунгистатическая активность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>levoglucosenone</kwd><kwd>antioxidant</kwd><kwd>anti-aggregational</kwd><kwd>cytotoxic</kwd><kwd>fungistatic activity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мифтахов М.С., Валеев Ф.А., Гайсина И.Н. Левоглюкозенон: свойства, реакции и использование в тонком органическом синтезе. Успехи химии. 1994; 63(10): 922–36. https://doi.org/10.1070/RC1994v063n10ABEH000123</mixed-citation><mixed-citation xml:lang="en">Miftakhov M.S., Valeev F.A., Gaisina I.N. Levoglucosenone: the properties, reactions, and use in fine organic synthesis. Uspekhi khimii. 1994; 63(10): 922–36. https://doi.org/10.1070/RC1994v063n10ABEH000123 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Witczak Z.J. Levoglucosenone and Levoglucosans: Chemistry and Applications. ATL Press; 1994.</mixed-citation><mixed-citation xml:lang="en">Witczak Z.J. Levoglucosenone and Levoglucosans: Chemistry and Applications. ATL Press; 1994.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Witczak Z.J. Carbohydrate therapeutic: new developments and strategies. Carbohydr. Drug Des. 2006; 932: 25–46. https://doi.org/10.1021/bk-2006-0932.ch002</mixed-citation><mixed-citation xml:lang="en">Witczak Z.J. Carbohydrate therapeutic: new developments and strategies. Carbohydr. Drug Des. 2006; 932: 25–46. https://doi.org/10.1021/bk-2006-0932.ch002</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sarotti A.M., Zanardi M.M., Spanevello R.A., Suarez A.G. Recent applications of levoglucosenone as chiral synthon. Curr. Org. Synth. 2012; 9(4): 439–59. https://doi.org/10.2174/157017912802651401</mixed-citation><mixed-citation xml:lang="en">Sarotti A.M., Zanardi M.M., Spanevello R.A., Suarez A.G. Recent applications of levoglucosenone as chiral synthon. Curr. Org. Synth. 2012; 9(4): 439–59. https://doi.org/10.2174/157017912802651401</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Comba M.B., Tsai Y.H., Sarotti A.M., Mangione M.I., Suárez A.G., Spanevello R.A. Levoglucosenone and its new applications: valorization of cellulose residues. Eur. J. Org. Chem. 2018; 2018(5): 590–604. https://doi.org/10.1002/ejoc.201701227 https://elibrary.ru/yghrql</mixed-citation><mixed-citation xml:lang="en">Comba M.B., Tsai Y.H., Sarotti A.M., Mangione M.I., Suárez A.G., Spanevello R.A. Levoglucosenone and its new applications: valorization of cellulose residues. Eur. J. Org. Chem. 2018; 2018(5): 590–604. https://doi.org/10.1002/ejoc.201701227 https://elibrary.ru/yghrql</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Available at: https://www.way2drug.com/PassOnline/predict.php</mixed-citation><mixed-citation xml:lang="en">Available at: https://www.way2drug.com/PassOnline/predict.php</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Миронов А.Н., ред. Методические рекомендации по доклиническому изучению противоопухолевой активности лекарственных средств. Руководство по проведению доклинических исследований лекарственных средств. Часть 1. М.: Гриф и К; 2012: 642–56. https://elibrary.ru/sdewmp</mixed-citation><mixed-citation xml:lang="en">Mironov A.N., ed. Methodological Recommendations for Preclinical Study of Antitumour Activity of Drugs. Guidelines for preclinical studies of drugs. Part 1 [Metodicheskie rekomendatsii po doklinicheskomu izucheniyu protivoopukholevoi aktivnosti lekarstvennykh sredstv. Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv. Chast’ 1]. Moscow: Grif and K; 2012: 642–56. https://elibrary.ru/sdewmp (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Миронов А.Н., Бунатян Н.Д. Руководство по проведению доклинических исследований лекарственных средств. Часть 1. Москва: Гриф и К; 2012.</mixed-citation><mixed-citation xml:lang="en">Mironov A.N., Bunatyan N.D. Manual on Conducting Preclinical Studies of Drugs. Part 1 [Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv. Chast’ 1]. Moscow: Grif and K; 2012. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гуревич К.Г., Ураков А.Л., Клен Е.Э., Самородов А.В., Никитина И.Л., Халиуллин Ф.А. и др. Синтез и биологическая активность этиловых эфиров 2-[8-арилметилиденгидразино-3-метил-7-(1-оксотиетанил-3)-ксантинил-1]уксусных кислот. Химико-фармацевтический журнал. 2020; 54(3): 3–10. https://doi.org/10.30906/0023-1134-2020-54-3-3-10 https://elibrary.ru/llowuk</mixed-citation><mixed-citation xml:lang="en">Gurevich K.G., Urakov A.L., Klen E.E., Samorodov A.V., Nikitina I.L., Khaliullin F.A., et al. Synthesis and biological activity of ethyl 2-[8-arylmethylidenehydrazino-3-methyl-7-(1-oxothietan-3-yl)xanth-1-yl]acetates. Pharmaceutical Chemistry Journal. 2020; 54(3): 213–9. https://doi.org/10.1007/s11094-020-02182-2 https://elibrary.ru/qpedun</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Born G.V., Garrod D. Photometric demonstration of aggregation of slime mould cells showing effects of temperature and ionic strength. Nature. 1968; 220(5167): 616–8. https://doi.org/10.1038/220616a0</mixed-citation><mixed-citation xml:lang="en">Born G.V., Garrod D. Photometric demonstration of aggregation of slime mould cells showing effects of temperature and ionic strength. Nature. 1968; 220(5167): 616–8. https://doi.org/10.1038/220616a0</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Faizullina L.Kh., Khalilova Yu.A., Valeev F.A., Pavlov V.N., Samorodov A.V. Preparation of the adduct of levoglucosenone and resorcinol and its in vitro antiplatelet and anticoagulant activity. Chem. Heterocycl. Comp. 2021; 57(9): 966–9. https://doi.org/10.1007/s10593-021-03007-0 https://elibrary.ru/mvrfke</mixed-citation><mixed-citation xml:lang="en">Faizullina L.Kh., Khalilova Yu.A., Valeev F.A., Pavlov V.N., Samorodov A.V. Preparation of the adduct of levoglucosenone and resorcinol and its in vitro antiplatelet and anticoagulant activity. Chem. Heterocycl. Comp. 2021; 57(9): 966–9. https://doi.org/10.1007/s10593-021-03007-0 https://elibrary.ru/mvrfke</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Халиуллин Ф.А., Маматов Ж.К., Тимирханова Г.А., Самородов А.В., Баширова Л.И. Синтез, антиагрегационная и антиоксидантная активность солей 2-[(1-изо-бутил-3-метил-7-(тиетанил-3)ксантин-8-ил)тио]уксусной кислоты. Химико-фармацевтический журнал. 2020; 54(9): 9–14. https://doi.org/10.30906/0023-1134-2020-54-9-9-14 https://elibrary.ru/acvypx</mixed-citation><mixed-citation xml:lang="en">Khaliullin F.A., Mamatov Z.K., Timirkhanova G.A., Samorodov A.V., Bashirova L.I. Synthesis, antiaggregant, and antioxidant activity of 2-{[1-iso-butyl-3-methyl-7-(thietanyl-3)xanthin-8-yl]thio}acetic acid salts. Pharmaceutical Chemistry Journal. 2020; 54(9): 891–6. https://doi.org/10.1007/s11094-020-02293-w https://elibrary.ru/hkvozb</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Файзуллина Л.Х., Карамышева Л.Ш., Якупова Л.Р., Мигранов А.Р., Сафиуллин Р.Л., Валеев Ф.А. и др. Синтез и оценка антиоксидантной, антикоагуляционной и антиагрегационной активности аддуктов левоглюкозенона, содержащих метилзамещенные фенильные фрагменты. Химико-фармацевтический журнал. 2024; 58(6): 48–53. https://doi.org/10.30906/0023-1134-2024-58-6-48-53 https://elibrary.ru/trdsvg</mixed-citation><mixed-citation xml:lang="en">Faizullina L.Kh., Karamisheva L.Sh., Yakupova L.R., Migranov A.R., Safiullin R.L., Valeev F.A., et al. Synthesis and evolution of antioxidant, anticoagulation and antiagregation activities of levoglucosenone adducts containing methyl substituted of phenyl fragments. Khimiko-farmatsevticheskii zhurnal. 2024; 58(6): 48–53. https://doi.org/10.30906/0023-1134-2024-58-6-48-53 https://elibrary.ru/trdsvg (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Якупова Л.Р., Хайруллина В.Р., Герчиков А.Я., Сафиуллин Р.Л., Баймуратова Г.Р. Кинетические закономерности жидкофазного окисления 1,4-диоксана в присутствии ингибиторов. Кинетика и катализ. 2008; 49(3): 387–91. https://elibrary.ru/ikputr</mixed-citation><mixed-citation xml:lang="en">Yakupova L.R., Khayrullina V., Gerchikov A.Ya., Safiullin R.L., Baimuratova G.R. Kinetics of the liquid-phase oxidation of 1,4-dioxane in the presence of inhibitors. Kinetics and Catalysis. 2008; 49(3): 366–70. https://doi.org/10.1134/S0023158408030075 https://elibrary.ru/llmvbn</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sharipov B.T., Davidova A.N., Valeev F.A., Ryabova A.S., Galimzyanova N.F. Synthesis and fungicidal activity of methylsulfanyl methyl esters of levoglucosenone derivatives. Chem. Heterocycl. Compd. 2019; 55(1): 31–7. https://doi.org/10.1007/s10593-019-02415-7 https://elibrary.ru/rzmfri</mixed-citation><mixed-citation xml:lang="en">Sharipov B.T., Davidova A.N., Valeev F.A., Ryabova A.S., Galimzyanova N.F. Synthesis and fungicidal activity of methylsulfanyl methyl esters of levoglucosenone derivatives. Chem. Heterocycl. Compd. 2019; 55(1): 31–7. https://doi.org/10.1007/s10593-019-02415-7 https://elibrary.ru/rzmfri</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Grever M.R., Schepartz S.A., Chabner B.A. The National Cancer Institute: cancer drug discovery and development program. Semin. Oncol. 1992; 19(6): 622–38.</mixed-citation><mixed-citation xml:lang="en">Grever M.R., Schepartz S.A., Chabner B.A. The National Cancer Institute: cancer drug discovery and development program. Semin. Oncol. 1992; 19(6): 622–38.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Boyd M.R., Paull K.D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 1995; 34(2): 91–109. https://doi.org/10.1002/ddr.430340203</mixed-citation><mixed-citation xml:lang="en">Boyd M.R., Paull K.D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 1995; 34(2): 91–109. https://doi.org/10.1002/ddr.430340203</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Shoemaker R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer. 2006; 6(10): 813–23. https://doi.org/10.1038/nrc1951</mixed-citation><mixed-citation xml:lang="en">Shoemaker R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer. 2006; 6(10): 813–23. https://doi.org/10.1038/nrc1951</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Файзуллина Л.Х. Левоглюкозенон – биовозобновляемая платформа в стереоконтролируемых синтезах и превращениях аминопроизводных и ∆3-аддуктов: Автореф. дисс. … д-ра хим. наук. Уфа; 2022.</mixed-citation><mixed-citation xml:lang="en">Faizullina L.Kh. Levoglucosenone – a bio-renewable platform in stereocontrolled syntheses and transformations of amino derivatives and ∆3-adducts: Diss. Ufa; 2022. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Valgimigli L. Lipid peroxidation and antioxidant protection. Biomolecules. 2023; 13(9): 1291. https://doi.org/10.3390/biom13091291</mixed-citation><mixed-citation xml:lang="en">Valgimigli L. Lipid peroxidation and antioxidant protection. Biomolecules. 2023; 13(9): 1291. https://doi.org/10.3390/biom13091291</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
